Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

Common Respiratory Disorders

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

Vaccinations

Vaccinations

Drugs Used in Upper Respiratory Disorders: Overview

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Case series of carbapenemase-producing Enterobacteriaceae osteomyelitis: Feel it in your bones.

Journal of global antimicrobial resistance·2020

Same author

Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak.

Medecine et maladies infectieuses·2018

Same author

Impact of a systematic alert for antimicrobial treatment durations exceeding seven days in a university hospital.

The Journal of hospital infection·2018

Same author

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017

Same author

Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2017

Same author

Non-typhi Salmonella enterica urinary tract infections.

Medecine et maladies infectieuses·2017

Search research articles

Related Experiment Video

Updated: Jul 2, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

[Current data on vaccines for respiratory diseases].

¹Service des maladies infectieuses et tropicales, hôpital universitaire Raymond-Poincaré, Assistance publique-Hôpitaux de Paris, 92380 Garches, France. c.peronne@rpc.aphp.fr

Medecine Et Maladies Infectieuses

|August 30, 2008

Summary

Vaccination prevents many respiratory infections. New data in France highlights vaccines for Haemophilus influenzae, pneumococci, influenza, pertussis, tuberculosis, and varicella, improving public health outcomes.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Related Experiment Videos

Last Updated: Jul 2, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

Area of Science:

Medical Microbiology
Immunology
Public Health

Background:

Respiratory tract infections are a primary driver for antibiotic prescriptions.
Vaccination offers a key preventive strategy against several of these infections.
Recent advancements and updated recommendations focus on improving vaccine efficacy and coverage.

Purpose of the Study:

To review and present new data on vaccine development and recommendations in France for respiratory infections.
To highlight the impact of existing vaccines and the need for improved vaccination coverage.
To inform healthcare professionals and the public about current vaccination strategies.

Main Methods:

Review of recent epidemiological data and vaccine effectiveness studies.
Analysis of updated vaccination guidelines and recommendations in France.
Synthesis of information on novel vaccine candidates and their potential impact.

Main Results:

Development of a polyvalent vaccine against non-capsulated Haemophilus influenzae strains causing otitis media.
Evidence of significant reduction in invasive pneumococcal infections and otitis media with heptavalent conjugate vaccine, impacting adult pneumonia rates.
Insufficient influenza and pertussis vaccination coverage in key populations, with updated recommendations for at-risk groups and close contacts.
Revised recommendations for BCG (tuberculosis) vaccination, emphasizing high-risk infants and specific regions.
Varicella vaccination not universally recommended, but advised for naive teenagers to prevent adult respiratory complications.

Conclusions:

Ongoing vaccine development and updated recommendations are crucial for controlling respiratory tract infections.
Improving vaccination coverage in targeted populations, including healthcare workers and infants, is essential.
Vaccination strategies need continuous evaluation and adaptation to address evolving public health challenges.